Aveanna Healthcare Holdings Inc.
$6.87
▲
1.43%
2026-04-21 05:29:01
www.aveanna.com
NMS: AVAH
Explore Aveanna Healthcare Holdings Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.47 B
Current Price
$6.87
52W High / Low
$10.32 / $3.73
Stock P/E
6.54
Book Value
$0.93
Dividend Yield
—
ROCE
16.39%
ROE
6.16%
Face Value
—
EPS
$1.05
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Care Facilities
Employees
3,500
Beta
2.09
Debt / Equity
775.91
Current Ratio
1.32
Quick Ratio
1.32
Forward P/E
8.9
Price / Sales
0.56
Enterprise Value
$2.67 B
EV / EBITDA
9.24
EV / Revenue
1.1
Rating
Buy
Target Price
$9.7
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Leverage is relatively high.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Nutex Health Inc. | $109.28 | 11.86 | $761.5 M | 9.75% | 36.24% | 58.94% | $193.07 / $77.21 | $46.49 |
| 2. | Auna SA | $5.52 | 14.63 | $415.95 M | — | 14.53% | 6.54% | $7.39 / $4.46 | $6.11 |
| 3. | Option Care Health, Inc. | $28.77 | 21.68 | $4.5 B | — | 12.87% | 15.2% | $36.8 / $24.24 | $8.46 |
| 4. | AirSculpt Technologies, Inc. | $2.64 | — | $180.6 M | 0% | -0.99% | -14.06% | $12 / $1.51 | $1.36 |
| 5. | Acadia Healthcare Company, Inc. | $27.84 | — | $2.56 B | — | 7.76% | -40.96% | $28.48 / $11.43 | $21.55 |
| 6. | Chemed Corporation | $385.77 | 19.4 | $5.15 B | 0.62% | 27.27% | 25.28% | $593.8 / $365.2 | $71.44 |
| 7. | COMPASS Pathways plc | $9.46 | — | $639.93 M | — | 468.11% | -5.65% | $8.9 / $2.25 | $-0.55 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 662.48 M | 621.94 M | 589.55 M | 559.22 M | 519.87 M | — |
| Operating Profit | 72.53 M | 52.41 M | 83.43 M | 51.91 M | 47.11 M | — |
| Net Profit | 178.75 M | 14.06 M | 27.02 M | 5.19 M | 29.18 M | — |
| EPS in Rs | 0.82 | 0.06 | 0.12 | 0.02 | 0.13 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.43 B | 2.02 B | 1.9 B | 1.79 B |
| Operating Profit | 260.28 M | 141.28 M | 113.67 M | 33.17 M |
| Net Profit | 225.03 M | -10.93 M | -134.52 M | -662.03 M |
| EPS in Rs | 1.03 | -0.05 | -0.62 | -3.04 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.01 B | 1.66 B | 1.61 B | 1.71 B |
| Total Liabilities | 1.82 B | 1.79 B | 1.74 B | 1.72 B |
| Equity | 195.19 M | -122.09 M | -127.44 M | -4.17 M |
| Current Assets | 560.23 M | 392.67 M | 314.89 M | 269.75 M |
| Current Liabilities | 424.46 M | 402.17 M | 354.76 M | 326.5 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 125.86 M | 32.64 M | 22.67 M | -48.4 M |
| Investing CF | -22.3 M | -6.32 M | -8.79 M | -25.29 M |
| Financing CF | 5.41 M | 14.03 M | 10.85 M | 62.42 M |
| Free CF | 118.41 M | 26.32 M | 13.88 M | -60.41 M |
| Capex | -7.45 M | -6.32 M | -8.79 M | -12.01 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 6.82% | 6.02% | — | — |
| Earnings Growth % | 91.88% | 79.68% | — | — |
| Profit Margin % | -0.54% | -7.1% | -37.03% | — |
| Operating Margin % | 6.98% | 6% | 1.86% | — |
| Gross Margin % | 31.39% | 31.42% | 30.95% | — |
| EBITDA Margin % | 9.26% | 2.07% | -29.37% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.